Onyx Pharmaceuticals to Float Up to 5 Million New Shares

On Wednesday, Onyx Pharmaceuticals (UNKNOWN: ONXX.DL  ) announced it has priced 4.4 million shares of common stock to be floated in a follow-on offering on or about Jan. 22.

The proposed price per share, $81.50, if achieved, would yield approximately $358.6 million in gross proceeds for Onyx. From this sum would be deducted underwriting discounts, commissions, and other expenses related to the offering. Onyx may, however, reap more funds (as much as $53.8 million) from the offering if underwriters exercise all or part of a proposed 660,000-share overallotment offering.

Among other things, Onyx says that it will use the proceeds from this offering to fund its clinical development programs, research and development activities, and sales and marketing activities aimed at commercializing its Kyprolis multiple myeloma drug.

Shares of Onyx dropped 5% Wednesday, closing  at $79.28.

link


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2201837, ~/Articles/ArticleHandler.aspx, 9/17/2014 7:54:49 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement